SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Lundberg Anna 1977 ) srt2:(2020-2023)"

Sökning: WFRF:(Lundberg Anna 1977 ) > (2020-2023)

  • Resultat 1-10 av 11
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Lingman Framme, Jenny, 1977, et al. (författare)
  • Long-Term Follow-Up of Newborns with 22q11 Deletion Syndrome and Low TRECs
  • 2022
  • Ingår i: Journal of Clinical Immunology. - : Springer. - 0271-9142 .- 1573-2592. ; 42, s. 618-633
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Population-based neonatal screening using T-cell receptor excision circles (TRECs) identifies infants with profound T lymphopenia, as seen in cases of severe combined immunodeficiency, and in a subgroup of infants with 22q11 deletion syndrome (22q11DS).Purpose: To investigate the long-term prognostic value of low levels of TRECs in newborns with 22q11DS.Methods: Subjects with 22q11DS and low TRECs at birth (22q11Low, N=10), matched subjects with 22q11DS and normal TRECs (22q11Normal, N=10), and matched healthy controls (HC, N=10) were identified. At follow-up (median age 16 years), clinical and immunological characterizations, covering lymphocyte subsets, immunoglobulins, TRECs, T-cell receptor repertoires, and relative telomere length (RTL) measurements were performed.Results: At follow-up, the 22q11Low group had lower numbers of naïve T-helper cells, naïve T-regulatory cells, naïve cytotoxic T cells, and persistently lower TRECs compared to healthy controls. Receptor repertoires showed skewed V-gene usage for naïve T-helper cells, whereas for naïve cytotoxic T cells, shorter RTL and a trend towards higher clonality were found. Multivariate discriminant analysis revealed a clear distinction between the three groups and a skewing towards Th17 differentiation of T-helper cells, particularly in the 22q11Low individuals. Perturbations of B-cell subsets were found in both the 22q11Low and 22q11Normal group compared to the HC group, with larger proportions of naïve B cells and lower levels of memory B cells, including switched memory B cells.Conclusions: This long-term follow-up study shows that 22q11Low individuals have persistent immunologic aberrations and increased risk for immune dysregulation, indicating the necessity of lifelong monitoring.Clinical Implications: This study elucidates the natural history of childhood immune function in newborns with 22q11DS and low TRECs, which may facilitate the development of programs for long-term monitoring and therapeutic choices.
  •  
2.
  • Hammaréus, Filip, 1998-, et al. (författare)
  • Plasma type I collagen α1 chain in relation to coronary artery disease : findings from a prospective population-based cohort and an acute myocardial infarction prospective cohort in Sweden.
  • 2023
  • Ingår i: BMJ Open. - : BMJ Publishing Group Ltd. - 2044-6055. ; 13:9
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVES: To investigate the association between type I collagen α1 chain (COL1α1) levels and coronary artery disease (CAD) by using absolute quantification in plasma. Also, to investigate the correlates of COL1α1 to clinical characteristics and circulating markers of collagen metabolism.DESIGN: Life conditions, Stress and Health (LSH) study: prospective cohort study, here with a nested case-control design.Assessing Platelet Activity in Coronary Heart Disease (APACHE) study: prospective cohort study.SETTING: LSH: primary care setting, southeast Sweden.APACHE: cardiology department, university hospital, southeast Sweden.PARTICIPANTS: LSH: 1007 randomly recruited individuals aged 45-69 (50% women). Exclusion criteria was serious disease. After 13 years of follow-up, 86 cases with primary endpoint were identified and sex-matched/age-matched to 184 controls.APACHE: 125 patients with myocardial infarction (MI), 73 with ST-elevation MI and 52 with non-ST-elevation MI.EXCLUSION CRITERIA: Intervention study participation, warfarin treatment and short life expectancy.PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome was the association between baseline COL1α1 and first-time major event of CAD, defined as fatal/non-fatal MI or coronary revascularisation after 13 years. Secondary outcomes were the association between the collagen biomarkers PRO-C1 (N-terminal pro-peptide of type I collagen)/C1M (matrix metalloproteinase-mediated degradation of type I collagen) and CAD; temporal change of COL1α1 after acute MI up to 6 months and lastly, correlates between COL1α1 and patient characteristics along with circulating markers of collagen metabolism.RESULTS: COL1α1 levels were associated with CAD, both unadjusted (HR=0.69, 95% CI=0.56 to 0.87) and adjusted (HR=0.55, 95% CI=0.41 to 0.75). PRO-C1 was associated with CAD, unadjusted (HR=0.62, 95% CI=0.47 to 0.82) and adjusted (HR=0.61, 95% CI=0.43 to 0.86), while C1M was not. In patients with MI, COL1α1 remained unchanged up to 6 months. COL1α1 was correlated to PRO-C1, but not to C1M.CONCLUSIONS: Plasma COL1α1 was independently and inversely associated with CAD. Furthermore, COL1α1 appeared to reflect collagen synthesis but not degradation. Future studies are needed to confirm whether COL1α1 is a clinically useful biomarker of CAD.
  •  
3.
  •  
4.
  • Jarrick, Simon, 1977-, et al. (författare)
  • Immunoglobulin A nephropathy and ischemic heart disease : a nationwide population-based cohort study
  • 2021
  • Ingår i: BMC Nephrology. - : BioMed Central (BMC). - 1471-2369. ; 22:1
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Chronic kidney disease has been linked to cardiovascular disease and specifically ischemic heart disease (IHD), but large-scale population data in patients with immunoglobulin A nephropathy (IgAN) are missing.OBJECTIVE: To examine absolute and relative risks for IHD in patients with IgAN.METHODS: Population-based register-based cohort study in Sweden. We identified 3945 patients with biopsy-verified IgAN, and 19,272 age- and sex-matched reference individuals from the general population. To reduce residual confounding from genetic factors and early environmental factors we carried out secondary analyses, where we compared 3039 IgAN patients with 6729 siblings, whereas a spousal analysis consisted of 2377 married couples where one of the spouses had IgAN. Data on IHD and end-stage renal disease (ESRD) were retrieved from the nationwide Patient Register. Cox regression estimated hazard ratios (HRs) adjusted for matching variables, education, country of birth, cancer, diabetes mellitus, and other systemic inflammatory diseases.RESULTS: During a follow-up of 55,527 person-years (py; mean follow-up 14.1 years), 371 patients (9.4%) with IgAN developed IHD (6.7/1000 py), compared with 1070 (5.6%) in 287,677 py in reference individuals (3.7/1000 py). The corresponding adjusted HR was 1.86 (95%CI = 1.63-2.13), equivalent to one extra case of IHD per 34 IgAN patients followed-up for 10 years. HRs were similar in men and women with IgAN, but higher in the first year after diagnosis and in patients born outside the Nordic countries. Patients with IgAN were at increased risk of IHD also compared to siblings (HR = 2.07; 95%CI = 1.62-2-64) and spouses (HR = 1.91; 95%CI = 1.40-2.61).CONCLUSIONS: In this nationwide population-based study, patients with IgAN were at an 86% increased risk of future IHD.
  •  
5.
  • Lundberg, Anna, 1977-, et al. (författare)
  • Hur kan akademi och civilsamhälle samarbeta för att värna asylrätten?
  • 2022. - 1
  • Ingår i: 2015 Till asylrättens försvar. - : Verbal. - 9789189155930
  • Bokkapitel (populärvet., debatt m.m.)abstract
    • 2015. Året som skulle förändra livet för så många av oss.För vissa var det året då de behövde lämna sina hem och bege sig på flykt undan krig och fara. För andra var det året då de lade vardagen åt sidan och ägnade sig åt att guida, hjälpa, stötta och ta emot de som kom. Det var otvivelaktigt en tid av stress, ovisshet och rädslor men det som lever vidare hos oss idag är minnen av solidaritet, gemenskap och medmänsklighet i en svår tid.  Sverige efter 2015 är ett Sverige där vi behöver skriva en bok för att försvara något som inte bara är en grundläggande mänsklig rättighet utan också något människor gjort så länge vi existerat: att fly fara och att hjälpa de som flyr. Denna antologi är till asylrättens försvar. Den samlar många olika sorters texter och röster – politiker och aktivister, forskare och flyktingar, vänsterfolk och liberaler. Vi vill att alla ska hitta något de kan läsa och ta till sig. Asylrätten ska inte vara en ideologisk fråga utan en grundläggande mänsklig rättighet. En rättighet vi varken vågar eller vill kompromissa bort eftersom vi kan behöva nyttja den och eftersom vi inte vet vilka vi blir om vi inte hjälper människor som flyr.
  •  
6.
  • Lundberg, Johan, et al. (författare)
  • Determinants and Outcomes of Suicidal Behavior Among Patients With Major Depressive Disorder
  • 2023
  • Ingår i: JAMA psychiatry. - : American Medical Association (AMA). - 2168-6238 .- 2168-622X. ; 80:12, s. 1218-1225
  • Tidskriftsartikel (refereegranskat)abstract
    • IMPORTANCE Major depressive disorder (MDD) is an important risk factor of suicidal behavior, but the added burden of suicidal behavior and MDD on the patient and societal level, including all-cause mortality, is not well studied. Also, the contribution of various prognostic factors for suicidal behavior has not been quantified in larger samples.OBJECTIVE To describe the clinical and societal outcomes, including all-cause mortality, of suicidal behavior in patients with MDD and to explore associated risk factors and clinical management to inform future research and guidelines.DESIGN, SETTING, AND PARTICIPANTS This population-based cohort study used health care data from the Stockholm MDD Cohort. Patients aged 18 years or older with episodes of MDD diagnosed between January 1, 2012, and December 31, 2017, in any health care setting were included. The dates of the data analysis were February 1 to November 1, 2022.EXPOSURES Patients with MDD with and without records of suicidal behavior.MAIN OUTCOMES AND MEASURES The main outcomewas all-cause mortality. Secondary outcomes were comorbid conditions, medications, health care resource utilization (HCRU), and work loss. Using Region Stockholm registry variables, a risk score for factors associated with suicidal behavior within 1 year after the start of an MDD episode was calculated.RESULTS A total of 158 169 unipolar MDD episodes were identified in 145 577 patients; 2240 (1.4%) of these episodes, in 2219 patients, included records of suicidal behavior (mean [SD] patient age, 40.9 [18.6] years; 1415 episodes [63.2%] in women and 825 [36.8%] in men). A total of 11 109 MDD episodes in 9574 matched patients with MDD without records of suicidal behavior were included as controls (mean [SD] patient age, 40.8 [18.5] years; 7046 episodes [63.4%] in women and 4063 [36.6%] in men). The all-cause mortality rate was 2.5 per 100 person-years at risk for the MDD-SB group and 1.0 per 100 person-years at risk for the MDD-non-SB group, based on 466 deaths. Suicidal behavior was associated with higher all-cause mortality (hazard ratio, 2.62 [95% CI, 2.15-3.20]), as well as with HCRU and work loss, compared with the matched controls. Patients with MDD and suicidal behavior were younger and more prone to have psychiatric comorbid conditions, such as personality disorders, substance use, and anxiety, at the start of their episode. The most important factors associated with suicidal behavior within 1 year after the start of an MDD episode were history of suicidal behavior and age, history of substance use and sleep disorders, and care setting in which MDD was diagnosed.CONCLUSIONS AND RELEVANCE This cohort study's findings suggest that high mortality, morbidity, HCRU, and work loss associated with MDD may be substantially accentuated in patients with MDD and suicidal behavior. Use of medication aimed at decreasing the risk of all-cause mortality during MDD episodes should be systematically evaluated to improve long-term outcomes.
  •  
7.
  • Mahmood, Zeid, et al. (författare)
  • The effect of acute exercise on interleukin-6 and hypothalamic-pituitary-adrenal axis responses in patients with coronary artery disease
  • 2020
  • Ingår i: Scientific Reports. - : Nature Publishing Group. - 2045-2322. ; 10
  • Tidskriftsartikel (refereegranskat)abstract
    • Vulnerability to stress-induced inflammation has been linked to a dysfunctional hypothalamus–pituitary–adrenal (HPA) axis. In the present study, patients with known or suspected coronary artery disease (CAD) were assessed with respect to inflammatory and HPA axis response to acute physical exercise. An exercise stress test was combined with SPECT myocardial perfusion imaging. Plasma and saliva samples were collected before and 30 min after exercise. Interleukin (IL)-6 and adrenocorticotropic hormone (ACTH) were measured in plasma, while cortisol was measured in both plasma and saliva. In total, 124 patients were included of whom 29% had a prior history of CAD and/or a myocardial perfusion deficit. The levels of exercise intensity and duration were comparable in CAD and non-CAD patients. However, in CAD patients, IL-6 increased after exercise (p = 0.019) while no differences were seen in HPA axis variables. Conversely, patients without CAD exhibited increased levels of ACTH (p = 0.003) and cortisol (p = 0.004 in plasma, p = 0.006 in saliva), but no change in IL-6. We conclude that the IL-6 response to acute physical exercise is exaggerated in CAD patients and may be out of balance due to HPA axis hypoactivity. It remains to be further investigated whether this imbalance is a potential diagnostic and therapeutic target in CAD.
  •  
8.
  • Olliver, Marie, et al. (författare)
  • ENABLE : an engine for European antibacterial drug discovery and development
  • 2021
  • Ingår i: Nature reviews. Drug discovery. - : Springer Nature. - 1474-1776 .- 1474-1784. ; 20:6, s. 407-408
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • ENABLE is an antibacterial drug discovery and development consortium formed as a publicprivate partnership in 2014 as part of the Innovative Medicines Initiative (IMI) New Drugs for Bad Bugs (ND4BB) programme. With the project soon ending, here we provide a brief overview and reflect on its achievements, strengths and weaknesses.
  •  
9.
  • Ong, Kwok Leung, et al. (författare)
  • Usefulness of Certain Protein Biomarkers for Prediction of Coronary Heart Disease
  • 2020
  • Ingår i: American Journal of Cardiology. - : EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC. - 0002-9149 .- 1879-1913. ; 125:4, s. 542-548
  • Tidskriftsartikel (refereegranskat)abstract
    • Identification of biomarkers can help monitor and prevent cardiovascular disease (CVD) risk. We performed an exploratory analysis to identify potential biomarkers for coronary heart disease (CHD) in participants from the Life Conditions, Stress, and Health study. A total of 1,007 participants (50% women), randomly selected from the general population, were followed for incident CHD at 8 and 13 years of follow-up. Plasma levels of 184 CVD-related biomarkers were measured in samples collected at baseline in 86 cases with CHD and 184 age- and sex-matched controls by proximity extension assay. Biomarker levels were presented as normalized protein expression values (log 2 scale). After adjusting for confounding factors, 6 biomarkers showed significant association with incident CHD at 13 years. In a sensitivity analysis, this association remained significant at 8 years for 3 biomarkers; collagen alpha-1(I) chain (COL1A1), bone morphogenetic protein-6 (BMP-6), and interleukin-6 receptor alpha chain (IL-6R alpha). When entering these biomarkers in the full adjustment model simultaneously, their association with incident CHD at 13 years remained significant, hazards ratio being 0.671, 0.335, and 2.854, respectively per unit increase in normalized protein expression values. Subjects with low COL1A1, low BMP-6, and high IL-6R alpha levels had a hazards ratio of 5.097 for incident CHD risk (p = 0.019), compared with those without. In conclusion, we identified COL1A1, BMP-6 and IL-6Ra as biomarkers for incident CHD over a long-term follow-up in this exploratory analysis. For COL1A1 and BMP-6 this has not been previously reported. Further studies are needed to confirm our findings and establish their clinical relevance. (C) 2019 Elsevier Inc. All rights reserved.
  •  
10.
  • Stenliden, Linnéa, 1964-, et al. (författare)
  • Lärares digitala kompetens före, under och efter covid-19.
  • 2020
  • Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
    • This study chrono-logically investigates teachers’ professional knowledge in relation to the digitally ‘boosted’ educational landscape caused by the Covid-19-pandemic. The aim is to describe how teachers employ their competences under extreme digitizedcircumstancescompared to ordinary, to greater extent analogically organizedschooling. The study is inspired by action research where five secondary and upper secondary teachers document their work between March 19 and April 2020. Contrastive analysis highlights qualitative aspects of teachers’ (digital) competence when teaching is affected by digital “interferences” in its corporeal and material framing, a dissolved spatiality and “truncated” senses/sensuousness.Employing different dimensions of knowledge in terms of intellectusand ratio, the study argues that subjective, emotional and relational processes of teachers’ digital competence need to be prioritized in contrast to the easily measurable aspects that tend to overrun the discussions about educational digitalizationand its knowledge in society.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 11
Typ av publikation
tidskriftsartikel (9)
annan publikation (1)
bokkapitel (1)
Typ av innehåll
refereegranskat (7)
övrigt vetenskapligt/konstnärligt (2)
populärvet., debatt m.m. (2)
Författare/redaktör
Jonasson, Lena, 1956 ... (3)
Lundberg, Anna, 1977 ... (3)
Kristenson, Margaret ... (2)
Stenliden, Linnéa, 1 ... (2)
Lampa, Erik, 1977- (1)
Dahlstedt, Magnus (1)
visa fler...
Lalander, Philip (1)
Lundberg, Anna (1)
Wernesjö, Ulrika (1)
Ekholm Selling, Kata ... (1)
Hughes, Diarmaid, 19 ... (1)
Hultdin, Magnus (1)
Degerman, Sofie, 197 ... (1)
Hammarström, Lennart (1)
Lundberg, Johan (1)
Swahn, Eva, 1949- (1)
Telemo, Esbjörn, 195 ... (1)
Alfredsson, Joakim, ... (1)
Karlén, Anders (1)
Sundström, Johan, Pr ... (1)
Ludvigsson, Jonas F. ... (1)
Fasth, Anders, 1945 (1)
Elsrud, Torun (1)
Olsson, Eva, 1960 (1)
Lundqvist, Christina ... (1)
Ekwall, Olov, 1968 (1)
Lundell, Anna-Carin, ... (1)
Hedlund, Daniel (1)
Warnqvist, Anna (1)
Festin, Karin (1)
Gruber, Sabine, 1958 ... (1)
Vingsbo Lundberg, Ca ... (1)
Brännström, Malin, 1 ... (1)
Belfrage, Anna Karin ... (1)
Harling, Tinna (1)
Baranczewski, Pawel (1)
Leanderson, Per, 195 ... (1)
Reimers, Eva (1)
Hellner, Clara (1)
Oskarsdóttir, Sólvei ... (1)
Björkholm, Carl (1)
Leval, Amy (1)
Borte, Stephan (1)
Cars, Thomas (1)
Chung, Rosanna (1)
Rye, Kerry-Anne (1)
Chung, Rosanna W S (1)
Thörn, Karolina, 197 ... (1)
Lundberg, Sigrid (1)
Harling, Martin, 197 ... (1)
visa färre...
Lärosäte
Linköpings universitet (5)
Uppsala universitet (3)
Karolinska Institutet (3)
Göteborgs universitet (2)
Umeå universitet (1)
Örebro universitet (1)
visa fler...
Mittuniversitetet (1)
visa färre...
Språk
Engelska (7)
Svenska (4)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (7)
Samhällsvetenskap (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy